3 Houston innovators to know this week

who's who

This week's roundup of Houston innovators includes Craig Ceccanti of T-Minus Solutions, Katie Eick of Rockin' Pets, Rollin' Vets, and Blair Garrou of Mercury. Photos courtesy

Editor's note: In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from venture capital to software — recently making headlines in Houston innovation.


Craig Ceccanti, founder and CEO of T-Minus Solutions

Words of wisdom from a founder who's done this all before. And then again. And again. Photo courtesy of T-Minus Solutions

After starting a company or two — or three — Craig Ceccanti has some observations on his own entrepreneurial journey. He also has some hard lessons learned, and he shared four of them in a guest column for InnovationMap.

"I’m not immune to making mistakes," he writes. "As a serial entrepreneur and having started, led, and mentored various successful companies, I have made some mistakes and have been lucky enough to learn from them." Read more.

Katie Eick, founder and CEO of Rockin' Pets, Rollin' Vets

Katie Eick, founder and CEO of Rockin' Pets Rollin' Vets joins the Houston Innovators Podcast to discuss her company's growth. Photo courtesy of Rollin' Vets

For years, Dr. Katie Eick wanted to provide mobile veterinary care for her patients, but the technology wasn't where it needed to be. She took a gamble and bought her first truck in 2016 as ridesharing and mobile ordering took off. A new business of convenience was booming, before blasting off again amid the pandemic.

Now, the founder and CEO of Rockin' Pets, Rollin' Vets says she's got the equipment, the market demand, and a $5 million round of investment to expand her business model.

The other challenge Eick says she faced early on was a misconception that mobile vet care was limited to vaccinations.

"We provide the highest level of veterinary care — right in your driveway," Eick says on this week's episode of the Houston Innovators Podcast, explaining how each of her trucks — she now has five — have the capability to provide all sorts of treatment. Read more.

Blair Garrou, founder and managing partner of Mercury

Blair Garrou will be recognized as the 2022 Trailblazer Award recipient at the Houston Innovation Awards Gala on November 9. Photo courtesy

The name Blair Garrou is quite familiar to most within Houston's startup and innovation ecosystem. As co-founder of Mercury, which launched in 2005, he's seen the city's tech world expand tenfold.

"Although we are in the midst of a recession, Houston continues to grow in three key industrial sectors of innovation – EnergyTech/ClimateTech, HealthTech, and SpaceTech. Our city has the opportunity to be a national leader in each of these sectors, and drive tremendous job growth in the future," he tells InnovationMap.

Garrou was nominated and selected by a group of judges to be the 2022 Trailblazer Award recipient, and will be honored at the Houston Innovation Awards Gala on November 9. Read more.

Katie Eick, founder and CEO of Rockin' Pets Rollin' Vets joins the Houston Innovators Podcast to discuss her company's growth. Photo courtesy of Rollin' Vets

Houston innovator grows mobile vet clinic amid growing industry challenges

HOUSTON INNOVATORS PODCAST EPISODE 156

For years, Dr. Katie Eick wanted to provide mobile veterinary care for her patients, but the technology wasn't where it needed to be. She took a gamble and bought her first truck in 2016 as ridesharing and mobile ordering took off. A new business of convenience was booming, before blasting off again amid the pandemic.

Now, the founder and CEO of Rockin' Pets, Rollin' Vets says she's got the equipment, the market demand, and a $5 million round of investment to expand her business model.

The other challenge Eick says she faced early on was a misconception that mobile vet care was limited to vaccinations.

"We provide the highest level of veterinary care — right in your driveway," Eick says on this week's episode of the Houston Innovators Podcast, explaining how each of her trucks — she now has five — have the capability to provide all sorts of treatment.

"We have a surgery suite, we have high-speed dental equipment — just like your dentist has. We have X-ray machines and ultrasound machines on almost all of our trucks," she explains. "We carry a full pharmacy on every truck."

It took a while to get to where she is today, which is caring for clients across Houston, with a recent expansion into The Woodlands and a soft launch in Austin. She plans to expand in Central Texas, including San Antonio, before tackling the northern region of the state. She also has a franchise model that she hopes to utilize to grow the brand nationally and even abroad.

"It was hard to educate the public on what we can do on those trucks," Eick adds "It took the first year, and once the word started to get out, then it snowballed."

Contributing to the snowball effect was the pandemic, which led pet owners to looking into alternative ways to access vet treatment. Now, Eick is focused on growing her team to support the company's growth. And, she adds, this is no easy task in today's employment climate.

"In this day and age, everyone has a shortage. ... The workforce is just smaller," Eick says. "There's a nationwide shortage of vets, and it's a confluence of things that have happened that I wished we saw coming."

Eick explains how the level of care vets are now able to — and expected to — give has increased with new technologies, specialist practices, and more. But the number of new vets with each graduating class has remained the same. Retention is also an issue, as the toll on veterinarians' mental health takes providing such frequent end of life care — on top of an increasingly busier schedule.

Eick shares more on the show about her observations on the current challenges within the industry as well as how she's innovating within her own practice to combat these obstacles. Listen to the interview below — or wherever you stream your podcasts — and subscribe for weekly episodes.


This week's roundup of Houston innovators includes Enrique Gomez of Texas Medical Center Innovation, Katie Eick of Rockin' Pets Rollin' Vets, and Jim Gable of Chevron. Courtesy photos

3 Houston innovators to know this week

who's who

Editor's note: In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from health care innovation to energy — recently making headlines in Houston innovation.

Enrique Gomez, entrepreneur in residence at Texas Medical Center Innovation

Enrique Gomez joins the Houston Innovators Podcast to discuss Houston as an oncology innovation hub. Photo via TMC.edu

When it comes to leading oncology innovation, Houston has a seat at the table, Enrique Gomez, entrepreneur in residence at Texas Medical Center Innovation's Accelerator for Cancer Therapeutics, says on the Houston Innovators Podcast.

"Houston is a place where everyone looks at when it comes to novel research and approaches to treating cancer," Gomez says. "The landscape here is going to be accelerated because we see much more collaboration between the founding institutions — and that's a very important element of growth. Houston has no comparison to any other place in terms of what's going on here and the level and quality of research." Click here to read more and stream the episode.

Katie Eick, founder of Rollin' Vets

Katie Eick always wanted to be able to offer mobile services. Photo courtesy of Rollin' Vets

Houston-based Rockin' Pets, Rollin' Vets, a full-service mobile veterinary clinic based in Houston, has closed a $5 million equity raise with plans to expand across the Lone Star State. Founded by Dr. Katie Eick, who is the company's CEO, Rollin’ Vets Group flips the switch on pet health care by bringing vets to its patients' homes.

This fresh funding helps Eick take that first step toward expansion. According to a news release, Rockin’ Pets, Rollin’ Vets expects to have a presence in Dallas and Austin by March of next year.

“This equity raise allows us to not only hire additional talent, but also increase our mobile clinic fleet, while expanding into other cities at an expedited rate. There is a vast opportunity to serve animals and people that need non-traditional veterinary care in other Texas markets. We are ready to tap into these markets and bring convenient, state-of-the-art care straight to pet owners’ doorsteps,” says Eick in the release. Click here to read more.

Jim Gable, incoming vice president of innovation and president of Chevron Technology Ventures

Barbara Burger has led Chevron's innovation efforts for almost a decade and is passing the responsibilities to Jim Gable. Photo courtesy

Barbara Burger, vice president of innovation at Chevron and president of Chevron Technology Ventures, is retiring, and passing the role to Jim Gable.

Gable brings his 23 years of experience to the role. Based in Chevron's office on the West Coast, he will be relocating to Houston, per the release. He currently oversees the development and deployment of downstream-related technology for Chevron.

“CTV has a 22-year history of investing in startups across a wide cross section of energy innovation and a track record of collaboration to bring innovation to scale,” Bonner continues. “Jim’s experience at Chevron is deep and diverse. Combined with his technology commercialization experience with CTV early in his career, as well as in his current role, Jim is poised to lead CTV to even greater success.” Click here to read more.

You'll paw-bably soon be seeing Rockin' Pets, Rollin' Vets vans across the Lone Star State. Photo courtesy of Rockin' Pets, Rollin' Vets

Houston mobile vet startup raises $5M to expand statewide

rollin' across texas

An innovative Houston company has closed a fresh round of funding in hopes of rolling its service out statewide.

Rockin' Pets, Rollin' Vets, a full-service mobile veterinary clinic based in Houston, has closed a $5 million equity raise with plans to expand across the Lone Star State. Founded by Dr. Katie Eick, who is the company's CEO, Rollin’ Vets Group flips the switch on pet health care by bringing vets to its patients' homes.

This fresh funding helps Eick take that first step toward expansion. According to a news release, Rockin’ Pets, Rollin’ Vets expects to have a presence in Dallas and Austin by March of next year.

“This equity raise allows us to not only hire additional talent, but also increase our mobile clinic fleet, while expanding into other cities at an expedited rate. There is a vast opportunity to serve animals and people that need non-traditional veterinary care in other Texas markets. We are ready to tap into these markets and bring convenient, state-of-the-art care straight to pet owners’ doorsteps,” says Eick in the release.

Currently, the company has five mobile units staffed by seven veterinarians and 12 skilled veterinary technicians. The company’s capabilities include wellness and illness exams, in-house labs, radiology, end-of-life care, routine surgeries, laser therapy and dental procedures — all within the Greater Houston area. The service plans to expand into The Woodlands in January.

Last year, the company raised $1 million in angel investment and crowdfunding on NextSeed. Patrick Lewis, CFO for Rollin’ Vets Group, says in the release that the capital was raised by a number of individuals, many of whom had prior investments in the pet care industry.

Eick founded her company in 2015 and was seeing steady growth as delivery and on-demand services like Uber, DoorDash, etc. increased in use and awareness of mobile services. Eick previously told InnovationMap that the pandemic really cemented the efficacy of mobile services.

While the company is focused on a Texas expansion for now, it's been in Eick's plan to expand even more broadly for a while.

"We're aiming to be a nationwide brand," Eick previously told InnovationMap.

Katie Eick always wanted to be able to offer mobile services.Photo courtesy of Rollin' Vets

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

4 Houston health tech startups advancing medical innovation

meet the finalists

Houston has been driving medical innovation for decades. And thanks to leading hospitals, cutting-edge research and breakthrough technologies, the region’s healthcare ecosystem continues to improve how patients are diagnosed, treated and cared for.

The Health Tech Business category in our 2025 Houston Innovation Awards will honor an innovative startup within the health and medical technology sectors.

Four forward-thinking businesses have been named finalists for the 2026 award. This year's finalists, selected by our esteemed panel of judges, range from a startup developing miniaturized medical technologies for space to a company using AI to help develop cancer treatment plans.

Read more about these businesses, their innovative founders, and how they're shaping the future of health care below.. The 2026 winners will be announced on InnovationMap.com in mid-November.

Bairitone Health

Bairitone Health is bringing anatomy imaging for sleep apnea to the home environment. The company's platform maps users' anatomy during natural sleep using a facial patch to determine the root cause of airway obstruction. It then offers effective therapies for each patient.

The company was founded in 2022 in the Texas Medical Center's Biodesign program by CEO Meagan Pitcher, CTO Onur Kilic and chief medical officer Britt Cross. It was a member of Activate Houston's inaugural cohort and has participated in numerous accelerators and incubators. The company raised an oversubscribed seed round for $2.4 million earlier this year and received Breakthrough Device Designation from the Food and Drug Administration in April.

InformAI Inc.

InformAI Inc. develops fit-to-purpose AI solutions for the clinical setting. Its RadOncAI product recently received FDA 510(k) clearance. The product uses AI to create a first-pass radiation therapy dose plan for complex head and neck cancers in an effort to eliminate bottlenecks in radiation planning and ultimately cancer treatment. The company has also developed AI products for sinus disease detection and 3D organ reconstruction.

CEO Jim Havelka founded the company in 2017. It is participating in the Mayo Clinic Accelerate Platform. It has raised about $4 million in seed funding and has received numerous non-dilutive grants from the National Science Foundation, the National Institutes of Health and the Cancer Prevention and Research Institute of Texas. The company shared in its application that it plans to launch a Series A fundraising round and submit an FDA 510K application for its organ reconstruction product, Voluquant, by the end of 2026.

Prana Surgical

Prana Surgical is developing a minimally invasive surgical platform for small, hard-to-reach lung nodules that may be cancerous. The company's Prana System cleared U.S. Food and Drug Administration (FDA) approval earlier this year.

Prana Surgical was originally founded as Prana Thoracic in 2022. It has participated in numerous accelerators, including the Texas Medical Center Innovation Accelerator in 2023 and the IGNITE Health accelerator in 2022. It raised $6 million in Series A funding rounds in 2023 and 2024 , with a Series B currently ongoing. The company said in its application that it is currently moving into the next stage of clinical validation and revenue generation in the U.S., in addition to preparing its manufacturing and commercial infrastructure for broader use.

Skybound MedTech

Skybound MedTech develops technologies that aim to address the health risks of long-duration spaceflight. Its compact, miniaturized medical technologies can deliver complex therapies without a physician.

CEO Matthew Kuhn, who previously founded Taurus Vascular, founded Skybound last year. The company emerged from stealth in January after raising a $1.25 million Series A round. It plans to advance its lead dual-use platform into critical preclinical validation in November, the company shared in its application. It is currently raising a $25 million Series A round and is pursuing federal research partnerships with DARPA and ARPA-H.

Generation Park lands new facility to scale xeno-organ production

Organ innovation

Maryland-based United Therapeutics Corp. has opened a new 77,448-square-foot facility to manufacture xeno-organs in Northeast Houston’s growing biotech hub, Generation Park.

The new Houston location is United Therapeutics’ third Designated Pathogen-Free (DPF) site, named for transplant pioneers Dr. Bartley P. Griffith and Dr. Robert A. Montgomery. The company says the new facility will enable it to scale commercial production of its xeno-organs once they receive regulatory approval.

An existing DPF facility in Virginia is supporting clinical trials for the xeno-organs, and a third site in Minnesota will also focus on commercialization with the Houston site, according to the company.

Xeno-organs are organs taken from a non-human animal source and transplanted, implanted or infused into a human recipient.

Currently, United Therapeutics is advancing clinical trials to support a Biologics License Application with the U.S. Food and Drug Administration for its investigational-stage xenotransplantation, UKidney, UThymoKidney and UHeart products. The products all involve working with the genes from humans and pigs.

In 2025, Chron.com reported the company was working to construct an estimated $96 million facility to breed genetically engineered animals. Head of investor relations at United Therapeutics Dewey Steadman told the Houston Business Journal in 2025 that the pigs’ DNA will be edited. In November 2024, a 53-year-old woman in Alabama received a transplanted kidney from UKidney that had 10 gene edits. She had the transplant removed in April 2025, after her body rejected it.

The Dr. Bartley P. Griffith and Dr. Robert A. Montgomery Xenograft Production Facility requires a “strictly controlled, biosecure barrier environment, including air filtration, filtered water, filtered feed supplies, and state-of-the-art decontamination entryways,” according to the company. Being pathogen-free means it includes calibrated air and water conduits to support the transplantability of xenograft products and to prevent contamination. For energy considerations, the building also features solar arrays.

“With our third xenograft production facility now open and clinical trials underway, United Therapeutics is moving closer to its goal of providing transplantable organs to the people who need them,” Martine Rothblatt, chairperson and CEO of United Therapeutics, said in a news release. “It is fitting that this facility is named for Dr. Griffith and Dr. Montgomery, whose first-in-human surgeries turned xenotransplantation from a theoretical possibility into a clinical reality.”

The facility, which wrapped construction in August, is located at 11848 Common Dock Dr. in Generation Park, which will house manufacturing sites for pharmaceutical heavyweights Bristol Myers Squibb and Eli Lilly. Last fall, Eli Lilly tapped Generation Park for its $6.5 billion manufacturing plant, and Bristol Myers Squibb made a $2.3 billion investment in August to bring its state-of-the-art site to the master-planned commercial district.

Elon Musk's SpaceX reports profit as AI and satellite businesses booms

Booming Business

SpaceX reported a bigger quarterly profit than expected on Tuesday, October 20, as its satellite communications and artificial intelligence businesses boomed.

The company, run by Elon Musk, posted a profit for the three months through September 2026 of $4.4 billion, or 35 cents per share, reversing a year-ago loss and easily topping Wall Street's expectations. Revenue soared to $14.6 billion, up 161%.

On a conference call with analysts, Musk suggested a merger with his electric car company Tesla might be in the works, something that has been rumored for months. He said both companies formed “special committees” of independent directors to discuss the issue, though he played down the chances of an imminent deal.

“Some people out there assume that a SpaceX and Tesla merger is a certainty,” he said. “I think that would be overstating it.”

The AI business became SpaceX's largest by revenue in the third quarter, although the Starlink satellite service remains the biggest profit generator.

“They beat across all metrics and the Starlink business looks to be accelerating,” said Dan Ives, an analyst at Yorkville Ives. “This is just what (Wall) Street wanted.”

The stock rose 7.5% in after-hours trading.

Musk also told analysts that for next month's launch of its Starship rocket, SpaceX will attempt to grab both the booster and ship with mechanical arms upon return to base, a key step toward demonstrating it can reuse the massive spacecraft.

“The only way that we can extend consciousness beyond Earth on a sustained basis is with a fully reusable orbital launch vehicle,” Musk said, calling the attempt, if successful, “a massive technology milestone.”

SpaceX hopes to get Starship on a regular launch pattern in preparation for NASA's upcoming lunar missions.

The company already has huge contracts with the federal government, and House Democrats have called for investigations into those contracts and Musk’s work with the Department of Government Efficiency. Musk has spent $276 million since July in support of Republican candidates.

In a filing for its initial public offering in June, SpaceX warned that a change in control of Congress could have a “material and adverse impact on our growth and competitive position.”

Musk recently drew criticism from politicians in Washington after speeds for a military version of SpaceX's satellite communications service were slowed for Ukraine following President Donald Trump's deal to get more diesel oil from Russia amid a push to end the war. The Wall Street Journal reported Tuesday that it was Musk who ordered the slowdown, impeding Ukraine’s use of drones along the front. SpaceX did not immediately respond to an Associated Press request for comment on the Journal story.

Both Trump and Musk have denied responsibility for the slowdown.

As midterm elections near, Musk on Monday promised to give one share of SpaceX to “every kid in America” next year, though he provided no details on how the distribution would be carried out. With communities nationwide protesting the construction of large data centers and concerns about AI safety, AI companies are trying to build goodwill. Anthropic pledged to commit 5% of its shares to a new “public benefit” fund.

SpaceX shares have been under pressure over concerns that the company was spending too much on major projects to compete with rivals such as Anthropic. The company said capital expenditures totaled $19.6 billion last quarter, nearly triple the figure from a year earlier, and it forecast spending would grow to $35 billion to $40 billion in the current quarter.

Shares of SpaceX closed Tuesday at $147.79, down from a peak near $201 after its IPO, which made Musk the world’s first trillionaire at the time. But the share prices for SpaceX and Tesla have since dropped, reducing his net worth to $925 billion, according to Forbes magazine.

Tesla reports third-quarter financial results Wednesday. Last week, Tesla unveiled a new Roadster sports car that in some versions may include thrusters allowing it to briefly fly using SpaceX technology — though experts say anything usable for drivers is a long shot.

View All Listings